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Cannabinoids are organic compounds, natural or synthetic, that bind to the cannabinoid 
receptors and have similar pharmacological properties as produced by the cannabis plant, 
Cannabis sativa. Gas chromatography (GC), e.g., GC-MS, is a popular analytical tool that has 
been used extensively to analyze cannabinoids in various matrices. 
Objective: 
To review published literature on the use of various GC-based analytical methods for the 
analysis of naturally occurring cannabinoids published during the past decade. 
Methodology: 
A comprehensive literature search was performed utilizing several databases, like Web of 
Knowledge, PubMed and Google Scholar, and other relevant published materials including 
published books. The keywords used, in various combinations, with cannabinoids being 
present in all combinations, in the search were cannabinoids, Cannabis sativa, marijuana, 
analysis, GC, quantitative, qualitative and quality control. 
Results: 
During the past decade, several GC-based methods for the analysis of cannabinoids have been 
reported. While simple 1D GC-MS and GC-FID methods were found to be quite common in 
cannabinoids analysis, 2D GC-MS as well as GC-MS/MS also were popular because of their 
ability to provide more useful data for identification and quantification of cannabinoids in 
various matrices. Some degree of automation in sample preparation, and applications of 
mathematical and computational models for optimization of different protocols were 
observed, and pre-analyses included various derivatisation techniques, and environmentally 
friendly extraction protocols. 
Conclusions: 
GC-based analysis of naturally occurring cannabinoids, especially using GC-MS, has 
dominated the cannabinoids analysis in the last decade; new derivatisation methods, new 
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 Cannabinoids are organic compounds, natural or synthetic, that bind to the 
cannabinoid receptors (endocannabinoid system) and have similar pharmacological 
properties as produced by the cannabis plant, Cannabis sativa1. However, often cannabinoids 
are referred to over 100 different compounds, 9-tetrahydrocannabinol (10, 9-THC or 
simply, THC) and cannabidiol (3, CBD) being the two major ones (Figure 1), biosynthesized by 
C. staiva2. The psychoactive property of C. sativa is fundamentally contributed by 9-THC (10), 
whilst the other major compound, cannabidiol (3), is believed to possess antipsychoactive 
property. Natural cannabinoids, also known as phytocannabinoids, are concentrated in a 
viscous resin produced in the glandular trichomes of C. sativa, and can be structurally 
classified into at least eight different classes, i.e., cannabigerols (5, CBG), cannabichromenes 
(1, CBC), cannabidiols (3, CBD), tetrahydrocannabinols (10, THC) and cannabinols (7, CBN), 
cannabielsoins, iso-tetrahydrocannabinols, cannabicyclols (2, CBCL), and cannabicitrans2. 
Medicinal cannabis generally has a higher level of cannabidiol CBD (>20%) than THC (~1%), 
whereas recreational cannabis contains higher amounts of THC (>20%) than CBD (~2%). 
Medicinal applications of phytocannabinoids, as supported by certain level of clinical 
evidence, include their uses for the treatment of chronic pain, some treatment resistant 
epilepsies, and chemotherapy induced nausea and vomiting. In addition to C. sativa, 
phytocannabinoids are also produced by several other plants including Acmella oleraceae, 
Echinacea angustifolia, E. purpurea, Helichrysum umbraculigerum and Radula marginata3. 
Since the discovery of the very first individual cannabinoid, cannabinol (7, CBN), in 
1940, by the British Chemist Robert S. Cann, and subsequent discoveries of cannabidiol (3, 
CBD) and then tetrahydrocannabinol (10, THC), several analytical tools and methods have 
been applied for the detection, identification, quantification and analysis of various naturally 
occurring cannabinoids, predominantly from the plant C. sativa, as well as in various biological 
matrices, e.g., the blood, urine, hair and nails, often linking to pharmacokinetic studies and/or 
forensic analysis2. Gas chromatography (GC)4 coupled with various detection technologies, 
e.g., FID and MS, is one of those analytical tools that has been used extensively to analyze 
cannabinoids5-8. Over the past decade, with the advancement of computational tools, MS 
databases, and various advanced detection technologies, GC has become one of the major 
tools in forensic, pharmacokinetic and phytochemical analysis of naturally occurring 
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cannabinoids. This review aims to capture the developments in GC methods applied to 
cannabinoids analysis since 2009, and to appraise the scientific publications in this topic 
published in the past decade.  
2   GAS CHROMATOGRAPHY (GC)  
 Gas chromatography (GC) is a chromatographic technique that is used for the 
separation and analysis of compounds, which can be vaporized without decomposition, from 
various matrices4. In this chromatography, the mobile phase is an inert gas, e.g., helium, 
whilst the stationary phase is a microscopic layer of liquid or polymer on an inert support, 
often a glass or metal tubing, called GC column (Figure 2). The most commonly used detectors 
with a GC are flame ionization detector (FID) and thermal conductivity detector (TCD), but the 
use of a mass spectrometer (MS) with different ionization modes has recently become routine 
in most of the analytical labs. Other types of detectors used infrequently with a GC may 
include alkali flame detector (AFD), atomic emission detector (AED), dry electrolytic 
conductivity detector (DELCD), electron capture detector (ECD), flame photometric detector 
(FPD), helium ionization detector (HID), nitrogen-phosphorus detector (NPD), photo 
ionization detector (PID), pulsed discharge ionization detector (PDD) and thermionic 
ionization detector (TID). The most recent developments in detection technology for GC have 
enabled multiple hyphenation with MS and NMR together to offer GC-MS-NMR, and vacuum 
ultraviolet detector to give the new hyphenated technique GC-VUV; the use of an infrared 
detector with GC is also now available (GC-IRD). 
 Because of the quality and extent of structural information that can be obtained from 
MS data, GC-MS, and GC-MS/MS, also known as tandem MS gas chromatography, have now 
been used routinely for the analysis of various types of natural products, including 
cannabinoids. In GC-MS, electron impact (EI) ionization mode is the most popular mode for 
the analysis of cannabinoids as this mode produces MS spectra that contain characteristic 
fragment ion peaks essential for the identification of compounds. However, in this interface, 
in the most cases, the molecular ion is absent because of the extent of fragmentation of any 
molecule. Softer ionization techniques, e.g., chemical ionization (CI), that offers information 
on molecular ions, is also frequently used with GC nowadays for the analysis of cannabinoids. 
It can be mentioned that GC-MS analysis of cannabinoids is not necessarily restricted to the 
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use of these two ionization techniques, rather, other ionization techniques, e.g., photo 
ionization (PI) technique6, are also in use. 
 One of the major components of C. sativa is thermolabile tetrahydrocannabinolic acid 
(11, THCA) (Figure 1), which is the precursor of THC (10), formed through in situ heat-
mediated decarboxylation of THCA (11) during smoking, cooking, or at the hot injection port 
of any GC. Therefore, in a GC operation, THCA (11) cannot be detected, but its decarboxylated 
product, THC (10), can be. A GC method is typically simpler and faster than an HPLC method 
for the detection of cannabinoids, which make a GC method preferable to an HPLC method. 
In most of the routine analysis of cannabinoids, a GC-FID is the method of choice because of 
its simplicity and reliability in routine identification and quantification of cannabinoids in plant 
materials and/or other matrices. However, for correct identification of individual 
cannabinoids, a GC-MS is more appropriate. The use of a GC method for the determination 
of the potency of cannabis is based on the concentration of THC (10) and CBD (3).  
In the following sections/subsections various specific GC-based analytical methods for 
the analysis of cannabinoids in various matrices will be discussed. 
 
3   GC ANALYSIS OF NATURALLY OCCURRING CANNABINOIDS 
 Several publications published during the past decade on the use of GC-based 
methods for the analysis of cannabinoids demonstrate that GC remains to be one of the most 
popular methods of choice when it comes to cannabinoids analysis. The published literature 
also shows that there are various types of detection technologies can now be used for GC, 
and different mathematical and computation modelling as well as chemometric tools can 
make the analysis of GC data more useful and reliable.   
Different types of GC columns are available to date, and the correct choice of a GC 
column, along with the application of the correct detection technology, is crucial to success 
of cannabinoids analysis by GC. Generally, most columns used in cannabinoid analysis have 
small diameter and are thin-filmed nonpolar stationary phase (e.g., 100% dimethyl silicone) 
columns. However, nonpolar columns like 100% dimethyl silicone or 5% diphenyl in dimethyl 
silicone do not have adequate level of polarity to separate and distinguish cannabidiol (CBD, 
3) from cannabichromene (1, CBC), which is absolutely crucial in accurate determination of 
THC/CBD ratio. In such a situation, the use of an intermediate polarity column, e.g., 35% 
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diphenyl in dimethyl silicone column can be useful in achieving good separation of CBD (3) 
and CBC (1). Two typical GC starting conditions, one using a FID and the other employing an 
MS detector, for the analysis of cannabinoids are summarised in Table 1.  
3.1 GC analysis of cannabinoids in plant samples  
 Various GC-based analytical techniques have become quite popular in the analysis of 
cannabinoids in plant samples (Table 2), particularly in cannabis extracts. In fact, these 
methods are generally useful for chemical fingerprinting of plant extracts containing 
cannabinoids. Presence of cannabinoids, both qualitative and quantitative, depends on the 
extraction method used to extract cannabinoids from a plant matrix. While the traditional 
ways of extracting cannabinoids from plants involve solvent-based extraction methods, 
nowadays, more environmentally friendly extraction techniques, e.g., supercritical fluid 
extraction (SFE), have become desirable.  
Omar et al.9 reported a SFE method using supercritical CO2 and ethanol as a co-solvent 
to extract cannabinoids from marijuana samples, and used retention time locking GC-MS for 
the identification and quantification (in the range of 0.96-324 mg/g) of three major 
cannabinoids, THC (10), CBD (2) and CBN (7). The SFE method could successfully remove 
terpenes and volatile components, making GC-MS analysis of cannabinoids mixture less 
complicated. The parameters for the SFE were studied by means of a central composite design 
(CCD) to get the optimum extraction conditions, and principal component analysis (PCA)10 
was used to analyze data. Cannabinoids determination and quantification in the seeds of C. 
sativa were achieved by ultrasonic extraction using n-hexane followed by a simple GC-MS 
technique11. In this piece of work, chemometric tools10 were used to analyze data.  
Derivatization plays a pivotal role in GC-MS analysis of phytocannabinoids, as most of 
these cannabinoids are not volatile and only derivatization can make them volatile for GC 
analysis. Fodor and Molnar-Perl12 studied the role of derivatisation techniques in the analysis 
of phytocannabinoids, like THC (10), CBD (3), tetrahydrocannabivarin (13, THCV), 
tetrahydrocannabidivarin (12, CBDV), CBC (1), cannabicyclol (2, CBCL), cannabigerol (5, CBG), 
CBN (7), 11-OH-THC (8) and THCA (11), by GC-MS. The same group reported alkylsilyl 
speciation by trialkylsilylation and direct sample preparation (solvent free) of cannabinoids, 
THC (10), CBD (2), THCA (11), CBN (7), 11-OH-THC (8), CBN (1) and CBG (5), of plant origins for 
subsequent GC-MS analysis13. A GC-MS and GC-FID based quantification of cannabinoids 
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present in cannabis olive oil preparation, which is the first choice as a concentrated extract of 
cannabinoids for medicinal use, has recently been reported14. In this study, the effect of 
temperature and duration of extraction on the amounts of cannabinoids as well as the effect 
of temperature on decarboxylation of THCA (11) was evaluated. While a similar method was 
also reported for the analysis of cannabinoids in C. sativa inflorescence15, a fast GC-MS 
method has recently been developed and validated16 for the determination of cannabinoids 
in C. sativa inflorescence, where different derivatization methods have been tested aiming at 
avoidance of decarboxylation of carboxyl group of cannabinoids. Fast GC methods are based 
on six major principles: short columns, fast oven temperature ramp rates, high carrier gas 
linear velocities, narrow I.D. columns, hydrogen carrier gas and low film thickness. A fast GC 
offers 3-10 times faster analysis time than conventional GC, resulting in overall lower cost.  
As C. sativa contains over 550 compounds, including 113 cannabinoids and 120 terpenes, the 
quality control of medicinal cannabis for medical use has always been a challenging issue17. 
The profiles and contents of cannabinoids and terpenes vary quite considerably among 
various chemotypes of C. sativa. Therefore, appropriate quality control methods are essential 
for ensuring the quality of medicinal cannabis and thus optimizing the therapeutic outcome. 
In order to address the quality control aspects of medicinal C. sativa, Calvi et al.17 have 
validated a headspace-solid-phase-extraction method coupled with GC-MS as well as LC-
HRMS, providing in depth chemical profiling and fingerprinting of cannabinoids and terpenes 
in authorized medical grade C. sativa inflorescences and macerated cannabis oils. A simple 
GC-FID method for the determination and quantification of a series of acidic and neutral 
cannabinoids, tetrahydrocannabivarian (13, THCV), CBD (3), CBC (1), trans-(8)-
tetrahydrocannabinol (9, 8-THC), THC (10), CBG (5), CBN (7), cannabidiolic acid (4, CBDA), 
cannabigerolic acid (6, CBGA) and THCA (11), has been published recently18. This method has 
also been used for cannabinoids analysis in different parts, e.g., buds, leaves, roots and stems, 
of the micropropagated C. sativa. 1D GC-MS and 2D GC-MS (GC x GC-Quadrupole MS) 
methods have been shown to be useful for the simultaneous detection of seven cannabinoids: 
THC (10), CBD (3), THCA (11), CBN (7), CBG (5), CBDA (4) and CBC (1)19.  
3.2 GC analysis of cannabinoids in biological and forensic samples 
Marijuana, a cocktail of at least 30 different cannabinoids, generally prepared from 
crushing the leaves, flowers and even stems of C. sativa, is one of the oldest recreational and 
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addictive natural products used by the humans for centuries. However, the use of cannabis 
or marijuana is illegal in many countries, which necessitates the use of analytical tools to 
analyze biological samples like blood, bronchoalveolar liquid, and urine to detect marijuana 
usage (Table 3). After consumption of marijuana, THCA (11), which is the major metabolite of 
THC (10), is excreted in the urine as its glucuronide conjugate. It can be mentioned again that 
THCA (11) is also present in the crude marijuana, but is converted to THC (10) by heat during 
smoking. 
3.2.1 Bile samples 
Among the biological samples, perhaps the bile is the least studied forensic sample for 
the analysis of cannabinoids in humans. A simple GC-MS method, with the limit of detection 
of 0.30 ng/mL and the limit of quantification of 1 ng/mL, for the determination of THC (10) 
and THCA (11) in the bile samples from 21 forensic cases, was reported20. Solid-phase 
extraction (SPE) was employed and the cannabinoids were derivatized by silylation using N,O-
bis(trimethylsilyl)-trifluoroacetamide with 1% trimethylchlorosilane. The method also 
included protein precipitation with acetonitrile after enzymatic hydrolysis. 
3.2.2 Blood, plasma and serum samples 
Blood, plasma and serum samples are quite extensively used in forensic analysis to 
detect the consumption of cannabinoids (Table 3). Frazee et al.21 described a GC-MS protocol 
that involved the addition of deuterated internal standard of 9-THCA (11) into the blood or 
urine sample followed by hydrolysis of THCA-glucuronide by alkali. They used liquid-liquid 
extraction to extract THCA (11) from urine or blood samples, and derivatized THCA (11) to its 
trimethylsilyl adduct for GC-MS analysis. The amount of THCA (11) was quantified by 
comparison of the responses of the unknown sample to that of the calibrators using selected 
ion monitoring (SIM), which is an MS scanning mode in which a limited mass-to-charge ratio 
range is detected by the instrument, instead of the full spectrum range, and thus increases 
sensitivity. A simple GC-MS method was reported by DeLong et al.22 for the determination of 
CBC (1), which is the second most abundant cannabinoid in marijuana, and THC (10) in mouse 
blood and brain. Cannabinoids were extracted from homogenized blood and brain with ice-
cold acetonitrile, and trimethylsilyl derivatives were produced for the GC-MS analysis. A 2D-
GC-MS method for the analysis of cannabinoids in post mortem blood samples, extracted by 
a liquid-liquid extraction protocol (efficiency >75%), was found to be effective in the 
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determination and quantification of THC (10), CBD (2), CBN (7), THCA (11) and 11-hydroxy-9-
tetrahydrocannabinol (11-OH-THC, 8)23. Simple GC-MS methods have also been used 
extensively to determine cannabinoids in plasma samples using various extraction and sample 
preparation techniques. For example, Camargo et al.24 developed an efficient liquid-liquid 
extraction and GC-MS method for the determination of CBD (2) at a concentration range of 
2.5-250 ng/mL of plasma. 
An automated liquid-liquid extraction coupled with a GC-MS method was reported for 
the analysis of THC (10), THCA (11) and 11-OH-THC (8) from human blood serum samples after 
derivatization by N-methyl-N-(trimethylsilyl) trifluoroacetamide (MSTFA)25. As this method 
could detect and quantify THC (10) as low as 0.3 mu g/L of concentration, when extracting 
only 0.5 mL of blood serum, this method was deemed suitable for the limit of quantification 
for THC (10) of 1 mu g/L in driving under the influence of cannabis cases in Germany and other 
countries. A similar liquid-liquid extraction coupled with a GC-MS/MS method has recently 
been reported for the detection and quantification of major cannabinoids, THC (10), 11-OH-
THC (8), CBD (2) and THCA (11), from human blood plasma samples26. Cannabinoids were 
derivatized by MSTFA before GC-MS/MS analysis. 
Solid phase extraction (SPE) is the most commonly used sample preparation technique 
to extract THC (10) and its main metabolites from different biological specimens, e.g., blood 
plasma. The use of SPE employing anion exchange sorbent was found to be an effective 
method of extraction for THC (10), THCA (11) and 11-OH-THC (8) in blood plasma and serum 
samples, prior to GC-MS analysis27. The benefit of this anion exchange sorbent was that it 
allowed differential elution of cannabinoids; neutral cannabinoids THC (10) and 11-OH-THC 
(8) were eluted first, followed by elution of clean acidic cannabinoid, THCA (11). An improved 
GC-MS/MS-based method for quantification of THC (10), 11-OH-THC (8) and THCA (11) in 
whole blood samples from cannabis users, employing SPE, and multiple reaction monitoring 
(MRM) mode, also known as selective reaction monitoring (SRM) has been reported 
recently28, and this method has been demonstrated to be specific, precise, linear, and 
sufficiently sensitive for its application post-mortem samples. In this method, a combination 
of bis(trimethylsilyl)trifluoroacetamide (BSTFA) and trimethylchlorosilane (TMCS) (99:1) was 
used for derivatisation at 65oC for 30 min. 
Microextraction by packed sorbent (MEPS) is practically a mini-SPE technique, in 
which the sample and solvent volumes are significantly reduced, and the sorbent is packed 
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into a syringe, which can be used repeatedly. MEPS was successfully used to extract 
cannabinoids, THC (10), THCA (11) and 11-OH-THC (8), from human blood plasma, and GC-
MS/MS technique was used for the detection and quantification (in the range of 0.1-30 
ng/mL) of these cannabinoids29.  
Gottardo et al.30 have reported, for the first time, the use of atmospheric pressure 
chemical ionization gas chromatography tandem mass spectrometry (APGC-MS/MS) for the 
determination of cannabinoids, THC (10), 11-OH-THC (8), THCA (11), CBD (3), cannabidiol acid 
(4, CBDA) and CBG (5) in human serum samples, with the limit of quantifications in the range 
of 0.2-3 ng/mL. APGC interface displayed advantages over the conventional electron 
ionization (EI) or chemical ionization (CI) sources, which are most often used in the GC-MS 
analysis of naturally occurring cannabinoids.   
3.2.3 Breast milk 
 Human breast milk, a highly complex biological fluid, is not often used for forensic 
analysis of cannabinoids, but is used to detect cannabinoids to protect breast-fed infants from 
possible toxicities of cannabinoids. Cannabinoids extraction from this matrix is quite 
challenging because of its high lipid and protein contents. Silveira et al.31 published a method 
combining headspace solid-phase microextraction and GC-MS for the quantification of THC 
(10), CBD (3) and CBN (7) in human breast milk samples. The method was quite sensitive as 
evident from its limits of detection and quantification being 10 and 20 ng/mL, respectively, 
for all analytes, and could determine THC (10), CBD (3) and CBN (7) in human breast milk in a 
very low volume sample (0.05 mL).  
3.2.4 Bronchoalveolar lavages 
Rotolo et al.32 have developed a simple and robust GC-MS method for the 
identification and quantification of CBN (7), CBD (3), THC (10), 11-hydroxy-THC (11-OH-THC, 
8) and THCA (11) in bronchoalveolar lavages from hospitalized former or current tobacco 
smoker patients with lung disease and a long history of cannabis consumption and limited 
current tobacco use. This is the very first report on the analysis of cannabinoids in 
bronchoalveolar lavage samples, which has more medical implications than forensic values. 
Bronchoalveolar lavages, also known as bronchoalveolar washings, is a medical diagnostic 
procedure, where a bronchoscope is passed through the mouth or nose into the lungs and 
fluid is squirted into a small part of the lung and then collected for examination.  
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3.2.5 Hair samples 
Hair samples are one of the most frequently used forensic samples for the analysis of 
drugs of abuse or illegal drugs like cannabis. Hair analysis is used to monitor usage of drugs 
over long periods, and in recent years, headspace solid-phase microextraction has emerged 
as an important extraction method for this analysis. Emidio et al.33 described a GC-MS/MS 
method for the detection and quantification of THC (10), CBD (3) and CBN (7) from human 
hair samples using a combination of headspace solid-phase microextraction and GC linked to 
tandem MS. It can be noted that enhanced selectivity and sensitivity can be accomplished 
using the GC–MS/MS procedure, where the molecular ion or a fragment of the ion having 
greatest intensity is separated and exposed to a second fragmentation. This secondary 
fragmentation can then be separated and detected. The hair samples from cannabis users, 
were first decontaminated using petroleum ether, deionized water and dichloromethane 
under sonication, followed by digestion in NaOH solution, before GC-MS/MS analysis. An 
improved GC-MS/MS method for the determination of THC carboxylic acid (THC-COOH, 11) 
in hair samples was reported, where a GC-negative ion chemical ionization tandem MS (GC-
NCI-MS/MS) technique was used34. Instead of SPE, a bead-assisted liquid-liquid extraction 
was employed using an n-hexane/EtOAc solvent mixture. This method was found to be useful 
in the identification of THCA (11) in hair specimens from suspected cannabis abusers. 
A forensic standard procedure combining enzyme-linked immunoassay for screening 
and GC-MS for the detection of cannabinoids, e.g., THC (10), CBD (3) and CBN (7), in human 
hair samples, which were previously used for the detection of other drugs of abuse, was 
reported7.  A simple and rapid single-step tandem GC-MS method using electron impact (EI) 
ionization mode and liquid-liquid extraction for the analysis of cannabinoids, THC (10), CBD 
(3), CBN (7) and 11-OH-THC (8), in hair samples has recently been reported35. They used 
multiple reaction monitoring (MRM) transitions approach for the detection of all 
cannabinoids. This method showed excellent limit of detection with 0.03 pg/mg for 11-OH-
THC (8), and the range 0.3-1.4 pg/mg for the other three cannabinoids. Similarly, the 
analytical recovery was also good and was within the range of 68-97%. A simple SPE coupled 
with GC-MS/MS method for the determination of THC (10), CBD (3) and CBN (7) in hair 
samples from consumers of CBD rich cannabis extracts has been reported by Rodrigues et 
al.36. Another similar GC-MS/MS method using EI mode of ionization for simultaneous 
quantification of THC (10), CBD (3), CBN (7), THCA (11), 11-OH-THC (8) in human hair samples 
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has also been described, where SPE was chosen for sample clean-up, applying a mixed-mode 
anion exchange sorbent37, and the limit of detection (LOD) was 0.2 pg/mg for THCA (11) and 
11-OH-THC (8), and 2 pg/mg for THC (10), CBD (3) and CBN (7), respectively, which fulfils the 
Society of Hair Testing recommendations. It can be noted that although GC-MS/MS with NCI 
is still considered as the gold standard for achieving the highest sensitivity for the analysis of 
THCA (11) in human hair samples, it suffers from lack of flexibility in the chemical ionization 
mode, when compared to electron impact ionization mode. Paul et al.38 have published a GC-
MS/MS method for the identification and quantification of THC (10), CBD (3), CBN (7), THCA 
(11) and 11-OH-THC (8) in human hair samples from 10 volunteers after cosmetic application 
of cannabis oil. Hair samples were prepared by washing with methanol followed by cleaning 
up with liquid-liquid and SPE methods. 
3.2.6 Meconium samples 
Toxicological studies using maternal foetal matrices can be a suitable tool to assess 
drug use or abuse during pregnancy, including cannabinoids. Mantovani et al.39 have recently 
reported the analysis of cannabinoids in meconium matrix through identification and 
quantification of THCA (11). It is known that meconium is easier to collect than neonatal urine 
and provides a much longer window of exposure of up to 20 weeks. In this study, accelerated 
solvent extraction (ASE)4 was used for simultaneous extraction and hydrolysis of conjugated 
THCA (11) from meconium, followed by an SPE procedure. The ASE method was optimized by 
a multivariate statistic technique, the response of surface methodology (RSM)10. The software 
Design-Expert® (version 8) was used to design the Box-Behnken experiment and to evaluate 
the statistical analysis of the surface response results. The extracted cannabinoids were 
analyzed by a standard GC-MS method. Six meconium samples from babies whose mothers 
were drug users were used in this experiment, and it demonstrated satisfactory performance 
to confirm foetal cannabis exposure. 
3.2.7 Oral fluid samples 
Two dimensional gas chromatography-mass spectrometry (2D-GC-MS)40, is a powerful 
technique where two different GC columns are used to facilitate simultaneous separation of 
multiple compounds in a complex mixture. As cannabis samples contain multiple compounds 
that belong to cannabinoid class, 2D-GC-MS could be quite useful in the identification and 
quantification of multiple cannabinoids present in a biological sample, which would otherwise 
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be difficult to achieve by conventional 1D GC-MS because of different physicochemical 
characteristics and concentrations of cannabinoid components present in a sample. A 2D-GC-
MS method was reported for the simultaneous identification and quantification of 9-THC 
(10), CBD (3), CBN (7), 11-hydroxy-THC (8) and THCA (11) extracted by SPE from an oral fluid 
sample41. In this experiment, both electron ionization and negative chemical ionization 
techniques were used. This SPE-2D-GC-MS method demonstrated efficient quantification of 
these five components in a single oral fluid specimen collected with the Quantisal™ device. A 
GC-MS/MS was developed for the quantification of THCA (11) in human oral fluid samples, 
collected from individuals participating in controlled cannabis studies, with the Quantisal and 
Oral-Eze oral fluid collection devices, and derivatizing by hexafluoroisopropanol and trifluoro 
acetic anhydride42. This method reduced analysis time by 9 min per sample compared to 2D-
GC-MS and extended the capability of quantification.  
3.2.8 Urine samples 
Human urine samples are popular in forensic toxicological analysis for the 
determination of various illegal drugs, including cannabinoids, and their metabolites. A 2D-
GC-MS method was validated for the identification and quantification of cannabinoids 
present in a urine sample, and was shown to be potentially useful in the monitoring of 
cannabinoid pharmacotherapy and illicit cannabis use43. A GC-MS method was also reported 
for the determination of CBG (5), which in its acid form is one of the major intermediates in 
the biosynthesis of cannabinoids in C. sativa, in urine samples of cannabis users44. The study 
demonstrated that, like other cannabinoids, CBG (5) also enters the body during smoking 
cannabis and is excreted in the urine in its conjugated glucuronide form. De Barbanter et al.45 
published a rapid and sensitive GC-based method for the determination of THCA (11) in urine 
samples. It can be noted that the detection of cannabis abuse is generally dependant on the 
quantification of the most important metabolite THCA (11) in urine. This reported method 
comprised a quick (4 min) GC-MS/MS method with a fast sample preparation involving 
microwave-assisted derivatisation. The total process only needed 30 min and required only 1 
mL of urine sample. The extraction and derivatisation processes were rather simple, and 
involved the spiking of 1 mL of urine with 50 mL of the internal standard (0.5 mg/mL of THCA), 
hydrolysis by incubation for 7 min at 56-58oC after addition of 100 mL of 6M NaOH solution, 
adding 1.5 mL of acetic acid and 10% EtOAc in n-hexane, vortexing for 1 min, transferring of 
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the organic phase, evaporation under nitrogen, and finally, derivatization of the dried sample 
using 20 mL of acetonitrile, 50 mL MSTFA and 50 mL of MSTFA/ethanethiol/NH4I (500:4:2) in 
a microwave reactor at 750 W during 1.5 min. A similar GC-MS method was developed for 
simultaneous determination of amphetamines, opiates and THCA (11) in human urine 
samples, where similar sample preparation protocol, and two different spin columns packed 
with C18 and mixed-mode C18 strong anion exchange bonded monolithic silica were used prior 
to GC-MS analysis46. Derivatization was accomplished by N,O-
bis(trimethylsilyl)trifluoroacetamide (BSTFA)-trimethylchlorosilane (TMCS) and N-methyl-
bis(trifluoroacetamide) (MBTFA). This GC-MS method was used for forensic and clinical 
overdose or poisoning cases and could be suitable for routine analysis of drugs in biological 
matrices. Kim et al.47 also reported simultaneous determination of amphetamines and 
cannabinoids in urine samples using GC-MS, using trifluoroacetic anhydride and 
pentafluoropropanol for derivatisation.  
While the GC-MS methods used for cannabinoids analysis are fundamentally same or 
similar, various types of extraction methods, especially microextractions, have recently been 
employed to extract different cannabinoids from urine samples.  For example, a hollow fibre-
liquid phase microextraction (LPME) technique was employed to extract THCA (11) from urine 
samples prior to GC-MS analysis48. LPME is a microscale sample preparation technique, where 
target analytes are extracted from an aqueous sample through a supported liquid membrane 
that is immobilized in the pores of a porous polymeric material, e.g., a hollow fibre, and into 
a volume of acceptor solution (typically, 10-30 µL).  
3.2.9 Forensic samples of recreational drugs 
In addition to cannabinoids or cannabis being used on its own as recreational 
substance, nontraditional cannabinoids are also added to and hidden in various freely 
available recreational products, e.g., ‘Spice’ (an herbal blend, which was available freely in 
the UK until the end of 2009, and classified as Class B drug). A GC-MS method, using solid 
probe mass spectroscopy, where no liquid-liquid extraction is needed, was reported for the 
detection of illegal components like cannabinoids in ‘Spice’ and other similar herbal 
products49. In fact, cannabinoids are often added to various psychoactive substances like 
‘legal highs’ or ‘herbal highs’, and simple GC-MS analysis can be used to detect various 
cannabinoids in those substances50. 
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3.3 GC analysis of cannabinoids in pharmacokinetic and ADME studies 
 Whilst several published works mainly described the methods of detection and 
quantification of cannabinoids in various matrices, pharmacokinetic or ADME studies of 
cannabinoids using GC have been rather scarce in the past decade. Only a GC-MS based 
pharmacokinetic study of THC (10) and CBD (3) was carried out in dogs under cannabinoids 
therapy51, albeit studies on the clinical use of cannabinoids in veterinary medicine are rather 
limited, and appropriate analytical methodologies for the determination of cannabinoids in 
animals, especially in dogs.  
3.4 GC analysis of cannabinoids from miscellaneous samples 
 In addition to analyses of cannabinoids in plants, biological and forensic samples, GC 
methods are also applied for the detection of cannabinoids present in various other matrices, 
e.g., waster water52.  Two major cannabinoids that are found in waste water are THC (10) and 
THCA or THC-COOH (11). A GC-MS based method for the determination of THC (10) and THCA 
(11) in waste water was reported by Racamonde et al.52. Solid-phase microextraction 
technique was used to extract cannabinoids from water waste samples, and derivatized using 
N-methyl-N-(trimethylsilyl)trifluoroacetamide (MSTFA) and N-methyl-N-(tert-
butyldimethylsilyl)trifluoroacetamide (MTBSTFA) before GC-MS analysis revealing the 
presence of considerable amounts of cannabinoids in waste water. It is interesting to note 
that, to optimize the derivatisation step and parameters, a Box–Behnken response surface 
design10 was adopted, and the design was composed of a total of sixteen experiments, 
including four central points, covering derivatization times between 10 and 30 min, 
temperatures between 30 and 70 ◦C and volumes of MSTFA between 10 and 60 L, selected 
according to the literature for other analytes determined by on-fibre SPME silylation.  
Presence of cannabinoids in various food samples was studied by GC-FID (flame 
ionization detector). Flame-ionization detection (FID) is a good general detector for organic 
compounds in GC that detects the amount of carbon in a sample. Lalge et al.53 described a 
GC-FID method for the determination of THC (10), CBD (3) and CBN (7) in hemp seed powder, 
hemp oil and hemp protein, which are used in the preparation of various food items. THC (10) 






During the past decade, GC-based analytical methods, especially GC-MS techniques, 
have remained as one of the most popular methods for the analysis of naturally occurring 
cannabinoids. A number of new derivatisation methods, new ionization techniques, and 
mathematical models for method optimization have been introduced to make the GC-based 
methods even more suitable for cannabinoids determination and quantification in different 
matrices. 
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TABLE 1 Two typical starting GC conditions for the analysis of cannabinoids  
GC method Run time Column Carrier gas Injector Detector 
GC-FID 9 min 15 m x 0.53 mm x 0.5 m  4 mL/min 
hydrogen 
Capillary split injector, split liner with 
glass wool, 275 oC 
FID 
GC-MS 30 min 30 m x 0.25 mm x 0.25 m  1.3 mL 
helium 
Capillary split injector, split liner with 
glass wool, 275 oC 






TABLE 2 GC analysis of cannabinoids in plants 
Sample Extraction method Instrumentation Derivatization Detected cannabinoids 
Marijuana 
(Cannabis) 
Supercritical CO2 fluid 
extraction 




quadrupole MS (GC x 
GC-QMS or 2D GC-MS) 
N/A THC (10), CBD (2), THCA (11), CBN, CBG (5), 





GC-MS N/A THC (10), CBD (3), CBG (5), CBC (1) and CBN (7)11  
Cannabis sativa Ultrasonic extraction 
with n-hexane 
GC-FID Trimethylsilyl THCV (13), CBD (3), CBC (1), trans-(8)-
tetrahydrocannabinol (9, 8-THC), THC (10), CBG 
(5), CBN (7), cannabidiolic acid (4, CBDA), 
cannabigerolic acid (6, CBGA) and THCA (11)18  
Supercritical CO2 fluid 
extraction 
GC-MS Trimethylsilyl THC (10)54  
Cannabis indica 
and C. sativa 
N/A GC-MS Trialkylsilylation THC (10), CBD (3), THCA (11), CBN (7), 11-OH-





GC-MS and GC-FID Silylation CBD (3) and CBDA (4)15  
Extraction with 90% 
MeOH in chloroform 
under sonication 
Fast GC-MS Silylation and 
esterification 
CBD (3), CBDA (4), CBGA (6) and 9-






GC-MS and LC-HRMS N/A Several cannabinoids17  
Cannabis sativa 




quadrupole MS (GC x 
GC-QMS or 2D GC-MS) 
N/A THC (10), CBD (3), THCA (11), CBN (7), CBG (5), 




TABLE 3 GC analysis of cannabinoids in biological and forensic samples 
Sample Extraction from 
sample 
Instrumentation Derivatization Detected cannabinoids 
Bile Solid-phase 
extraction 
GC-MS Silylation using N,O-
bis(trimethylsilyl)trifluoroacetamide with 1% 
trimethylchlorosilane 
THC (10) and THCA (11)20  
Blood Liquid-liquid 
extraction 
GC-MS Trimethylsilyl THCA (3)21  
Liquid extraction 
with acetonitrile 





THC (10), CBD (3), CBN (7), 




GC-MS/MS Bis(trimethylsilyl)trifluoroacetamide and 
trimethylchlorosilane (99:1) 
THC (10), 11-OH-THC (8) and 
THCA (11)28 
Brain Liquid extraction 
with acetonitrile 
GC-MS Trimethylsilyl CBC (1) and THC (10)22 
Breast milk Headspace solid-
phase 
microextraction 





10% EtOAc in n-
hexane 
GC-MS Trimethylsilyl THC (10), CBD (3), THCA (11), 





trap tandem MS) 

















THC (10), CBD (3) , 11-OH-THC 









GC-MS/MS Trimethylsilyl THC (10), CBD (3), CBN, THCA 






THC (10), CBD (3), CBN (7), 










GC-MS N/A THCA (11)39 
Oral fluid Solid-phase 
extraction (SPE) 
2D-GC-MS N,O-bis(trimethylsilyl)-trifluoroacetamide, 
trifluoroacetic anhydride and 
hexafluoroisopropanol 
THC (10), CBD (3), CBN (7), 
and metabolites, 11-hydroxy-
THC (8) and THCA (11)41  





2D-GC-MS N,O-bis(trimethylsilyl) trifluoroacetamide with 
1% trimethylchlorosilane 
THC (10), CBD (3), 11-OH-THC 
(8) and THCA (11)43  
Liquid-liquid 
extraction 
GC-MS Trimethylsilyl CBD (3)24 
Liquid-liquid 
extraction 
GC-MS/MS N-methyl-N-(trimethylsilyl) trifluoroacetamide 
(MSTFA) 
CBD (3), THC (10), THCA (11), 





Trimethylsilyl THC (10), THCA (11), 11-OH-









GC-MS/MS N-methyl-N-(trimethylsilyl) trifluoroacetamide 
(MSTFA) 





GC-MS N-methyl-N-(trimethylsilyl) trifluoroacetamide 
(MSTFA) 
THC (10), 11-OH-THC (8), and 





GC-MS Trimethylsilyl THC (10), THCA (11), 11-OH-
THC (8)27  
Extraction with 
10% EtOAc in n-
hexane 
APGC-MS/MS N-methyl-N-(trimethylsilyl) trifluoroacetamide 
(MSTFA) 
THC (10), 11-OH-THC (8), 
THCA (11), CBD (3), CBDA (4) 
and CBG (5)30 
Urine Liquid-liquid 
extraction 
GC-MS Trimethylsilyl THCA (11)21  
GC-MS N-Methyl-N-(trimethylsilyl)trifluoroacetamide CBG (5)44  
GC-MS/MS Microwave-accelerated derivatisation. 
N-methyl-N-(trimethylsilyl)trifluoroacetamide 
(MSTFA), and MSTFA/ethanethiol/NH4I 
THCA (11)45  
GC-MS Tri-fluoroacetic anhydride and 
pentafluoropropanol 




(BSTFA)-trimethylchlorosilane (TMCS) and N-
methyl-bis(trifluoroacetamide) (MBTFA) 








liquid extraction   
GC-MS with solid 
probe 
N/A Nontraditional cannabinoids49  
31 
 





GC-MS N/A Cannabicyclohexanol50  
 
